Azopharma Acquires Clinical Site in Daytona Beach

Azopharma Product Development Group, Inc. has acquired Coastal Medical Research, Inc. (CMR), a clinical pharmacology facility in Daytona Beach, FL. The facility will operate under AvivoClin Clinical Services, Azopharma’s clinical pharmacology division. The facility will provide Phase I-III clinical services for all major therapeutic areas.
   
Phil Meeks, Azopharma’s chief executive officer, said, “We are truly excited about expanding our clinical pharmacology services. Not only does this expand the capabilities of AvivoClin it allows the Azopharma Product Development Group to more completely serve companies seeking full product development.”
   
The 15,000-sq.-ft. CMR facility includes 48 beds and the company plans to expand the facility to house more than 100 beds. Mr. Meeks added, “We believe we will provide added benefit to CMR’s current clients not only through our investment in the facilities and infrastructure, but by providing services critical to support clinical studies such as formulation, CTM manufacturing, and bioanalytical testing.”